3D Revolution: Better Cells, Better Meds. Growing 30% CAGR!

Webinar: January 28, 2015 – 12:00 p.m., U.S. Eastern time

Click to Register:  http://bit.ly/3DCellCultures

3D Cell Culture is a high-growth category of life science R&D tools and equipment, cells, and other consumables being used to build research and testing models that are more representative of human physiology.  Whereas genomics, proteomics and in silico models are enabling ever-richer hypotheses about biological pathways and mechanisms, researchers still rely on in vivo animal models and increasingly on in vitro (“in test tube”) models as the “last mile” to confirm them.

And with ever-escalating development costs and attrition rates for new drug candidates, the shortcomings of in vitro cultures using traditional 2D monolayer are increasingly calling for replacement or at least consideration of 3D alternatives.  The commercial landscape is now starting to mature past early adopter phase, and we forecast revenue growth of 30% CAGR over the next five years.

This market has a hyper-drive innovation landscape that is highly differentiated but with sufficient maturity and structure to be sustainable.  Part of our outlook is for some healthy consolidation including mergers and acquisitions of all sizes.

This free 45-minute BCC Research webcast with Robert Hunter will detail the technology and market landscape, as well as describe key application areas including cancer research, stem cell research, toxicology and safety testing, and liver and metabolic research. It is based on the report, 3D Cell Cultures: Technologies and Global Markets (BIO140A).

Click to Register:  http://bit.ly/3DCellCultures

3D Growing 30%- webinar




Better results, less side effects